Thirty years ago, as a psychology student, I was studying Skinner and Tolman's work. They compared the brain to a black boxbelieving it was inaccessible.
Wishing the contrary, I was eager to dive deep into the brain and understand how it generates behavior. In Per Andersen's lab I could do so. There we showed that enrichment increased the number of spines in hippocampal cells. I was thrilled when I saw the tiny spines in the confocal microscope! Later, John O'Keefe taught Edvard Moser and me how to record hippocampal single units, and in 2014 the three of us won the Nobel Prize for discovering the brain's positioning system. In just a couple of decades, we were contributing to a transformation of the ''black box'' to a functional understanding of cells deep in the brain.
This exemplifies how fast neuroscience is progressing. Development of molecular tools enabling control of specific cell populations during behavior, and machines outperforming humans in navigation through deep reinforcement learning with grid-like networks, fuel the progress. The final surprising development is a two-photon microscope reduced to 2 g, enabling studies of spine activity in behaving mice. These achievements were unthinkable ''back then'' when I was counting spines.
Thus, with this rapid development in neuroscience, it seems we are living in a time when the main limiting agent is our imagination and creativity. Groundbreaking discoveries are waiting for us! Human Functional Imaging, Past and Future Jack L. Gallant
University of California at Berkeley
Since the development of fMRI, human brain imaging research has undergone a continuous process of refinement. Advances in main magnetic field strength, read coil technology, and pulse sequence design have dramatically increased the spatial resolution of fMRI. New experimental paradigms have been developed for exploring complex, often naturalistic stimuli and tasks such as watching movies, listening to stories, or playing video games. And new methods of data analysis and modeling, such as voxel-wise encoding models, have provided powerful predictive models of functional activity. Over the next few decades, progress in all these areas is likely to continue. Most importantly, the upcoming generation of ultra-high-resolution fMRI machines will have sufficient resolution to image single cortical columns and layers, a level of detail far finer than the coarse topographic functional maps that can be recovered currently. These ultra-high-resolution measurements will help us bridge the gap between finely detailed studies of neural circuits in animals and the coarser information available from humans. Second, advances in modeling and experimental design will support efficient functional mapping in individuals rather than merely at the group level. Procedures for efficiently obtaining detailed functional maps in individuals will provide a means to move fMRI from the laboratory into the clinic, and will facilitate its routine use in diagnosis, prognosis, and monitoring of developmental and mental disorders and neurological disease.
Key to Unlocking Psychiatric Disorders

Hailan Hu
First Affiliated Hospital and School of Medicine, Zhejiang University
In neuroscience, many molecular and cellular principles have been uncovered to describe fundamental processes such as neuronal firing, synaptic plasticity, and neuron-glia interaction. Our understanding of the connection between specific neural circuits and behavioral states has also been advanced by revolutionary tools including optogenetics, chemogenetics, and in vivo calcium imaging. Bridging knowledge across these multiple levels is essential for tackling the mechanisms of psychiatric disorders, which are often caused by molecular impairments and manifest as neural circuit dysfunctions. While genetic approaches to identify the molecular cause can be impeded by the complex and multi-gene nature of the psychiatric diseases, drugs that induce or alleviate psychiatric symptoms may provide a key to peek into the secret of these disorders. Ketamine for depression is a good example, revealing the NMDA receptor as a potential molecular suspect. However, to make good use of these keys, we must fit them into the right locks-identifying at which neural circuits these molecules act for the relevant symptoms. While many circuits may undergo changes in disease, only one to a few core circuit(s) are likely accountable for the etiology. With localized drug application and circuit-specific manipulation tools, it has become possible to pinpoint these suspect circuit(s). In the future, there is high hope that discoveries in basic neuroscience will push the frontiers of psychiatric treatment.
Ancient Brain, Modern World
Randy L. Buckner
Harvard University
The human brain is mismatched to the modern world. Many mismatches, such as how drugs of addiction hijack reward circuitry and how our honed taste for calories is satisfied by fast food, are well studied. What may be less well known is that the mismatches are pervasive, affecting numerous aspects of brain biology, and further that they can be studied by considering directly how ancient brain circuitry is not aligned to the modern environment. For example, adolescence is a time of tremendous social maturation but also a minefield of bad behavioral outcomes and risk for mental illness. Ancient hunter-gatherers reached sexual maturity at age 17 or 18. How does accelerated maturation in today's adolescents affect neurodevelopmental cascades that have rates and triggers titrated to a markedly different course of development? And how is development shaped if brain systems specialized to tune social expectations through observation are now fed highlight reels of pretend lives on social media? We live in a new world with its novel opportunities and risks. Studying the brain in the context of its complex interactions with the modern environment will be critical for understanding how the human brain works and for translating lessons from animal models to the human condition. Our appetite for discovery must extend from sophisticated understanding of circuit mechanisms in the abstracted environment all the way through to asking how human circuits sculpt and respond in this world.
Bioengineering Advances
Molly M. Stevens
Imperial College London
The tissue engineering and regenerative medicine scientific community has embraced the challenge of developing strategies for repairing nervous tissue, a remarkably demanding task that works against the limited natural regenerative ability of a tissue with a high functional complexity. We are tackling new bioengineering challenges in bioelectronics to develop new biomaterials such as conductive polymers that have the potential to provide electrical and ionic stimulation to cells for enhanced tissue regeneration. Our growing understanding of molecular pathways and cell-material interactions has allowed us to design functionalized materials with stem cells and biologically relevant molecules to elicit neuronal survival and proliferation, axonal growth, topographic cell guidance, immunoregulation, and other interesting biological responses. At the intersection of biomedicine, materials science, and precision engineering, the emerging field of biofabrication is developing creative advanced manufacturing processes that merge the individually explored elements into single multifunctional structures in the attempt to replace neural grafting with tissue engineering strategies. We are seeing promising results of applications such as longitudinally aligned nanofiber conduits for guided growth and functionalized biohybrid hydrogel scaffolds and electrospun fibers for bridging gaps in severed nerves. We must continue to foster such integrative collaborations to bring together the last decades of creation and discovery into effective, multifunctional approaches for neuroregeneration.
Transcriptomes Illuminate Synaptic Network Plasticity
Stephen J Smith Allen Institute for Brain Science and Stanford University
The dynamic adjustment of synaptic networks necessary for stable brain function and for adaptation and learning depends mainly upon synaptic plasticity. Moreover, physiological studies suggest that every synapse in the brain exhibits multiple forms of activity-dependent and neuromodulatory plasticity. Ubiquitous, yet varied, synaptic plasticity is also suggested by the wide variety of neuromodulatory substances (e.g., neuropeptides) and receptors (e.g., GPCRs) expressed differentially in every neuron. Unfortunately, this profusion of synaptic plasticity mechanisms has posed formidable challenges for mechanistic analysis of the brain's highly heterogeneous synaptic networks. Fortunately, rapid advances in mRNA sequencing technologies now promise a breakthrough. A growing flood of deep, single-cell transcriptomic data has ushered in the prospect of classifying the brain's billions of diverse neurons into taxonomies comprising small numbers of discrete cell types, each complete with its own ''parts list'' of synaptic and plasticity-related signaling molecules. Highly multiplexed fluorescence microscopy methods are furthermore now poised to use these molecular cell-type taxonomies to place specific transcripts and synaptic signaling proteins into network architectural context, and thus to illuminate both network stabilization and network plasticity. The resulting insights are likely to directly impact the ways we think about neuropsychiatric disorders, choose targets for therapeutic drug development, and perhaps even how we adjust ''synaptic weights'' in the artificial neural nets common to today's most powerful machine learning tools.
